These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18842531)

  • 41. Predictive models in diagnosing indolent cancer.
    Bangma CH; Roobol MJ; Steyerberg EW
    Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hospice and emergency room use by disadvantaged men dying of prostate cancer.
    Bergman J; Kwan L; Fink A; Connor SE; Litwin MS
    J Urol; 2009 May; 181(5):2084-9. PubMed ID: 19286207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What will the emperor say? Screening for prostate cancer as of 2008.
    Concato J
    Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The psychosocial aspects of sexual recovery after prostate cancer treatment.
    Wittmann D; Northouse L; Foley S; Gilbert S; Wood DP; Balon R; Montie JE
    Int J Impot Res; 2009; 21(2):99-106. PubMed ID: 19158798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer survivorship: history, quality-of-life issues, and the evolving multidisciplinary approach to implementation of cancer survivorship care plans.
    Morgan MA
    Oncol Nurs Forum; 2009 Jul; 36(4):429-36. PubMed ID: 19581233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioids and cancer survivors: issues in side-effect management.
    Palos GR
    Oncol Nurs Forum; 2008 Nov; 35 Suppl():13-9. PubMed ID: 18980935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.
    Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson JE; Hugosson J;
    J Urol; 2008 Dec; 180(6):2423-9; discussion 2429-30. PubMed ID: 18930283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Surgical's innovations and perspectives in management of localized prostate cancer].
    Drouin SJ; Rouprêt M
    Prog Urol; 2009 Apr; 19 Suppl 1():S8-S11. PubMed ID: 19465335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
    Fuchsjäger M; Akin O; Shukla-Dave A; Pucar D; Hricak H
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):193-202. PubMed ID: 19398944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How prostate cancer support groups do and do not survive: British Columbian perspectives.
    Oliffe JL; Halpin M; Bottorff JL; Hislop TG; McKenzie M; Mroz L
    Am J Mens Health; 2008 Jun; 2(2):143-55. PubMed ID: 19477778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
    Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S
    BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seasons of survivorship revisited.
    Miller K; Merry B; Miller J
    Cancer J; 2008; 14(6):369-74. PubMed ID: 19060601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life in older women with early-stage breast cancer in the first year of survivorship.
    Loerzel VW; McNees P; Powel LL; Su X; Meneses K
    Oncol Nurs Forum; 2008 Nov; 35(6):924-32. PubMed ID: 18980923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of localized prostate cancer having a good prognosis may cause more harm than benefit].
    Ruutu M; Rannikko A; Malmi H; Vasarainen H; Mikkola A
    Duodecim; 2009; 125(14):1516-23. PubMed ID: 19711574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body image and quality of life in men with prostate cancer.
    Harrington JM; Badger TA
    Cancer Nurs; 2009; 32(2):E1-7. PubMed ID: 19258822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating prostate cancer, Part I: The big picture.
    Harv Mens Health Watch; 2008 May; 12(10):1-4. PubMed ID: 18700283
    [No Abstract]   [Full Text] [Related]  

  • 58. Optimizing the management of prostate diseases: prostate cancer. Introduction.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():1. PubMed ID: 18307684
    [No Abstract]   [Full Text] [Related]  

  • 59. What patient care technologies are in place at your institution? Programs deliver customized, personalized education and care.
    Berry D
    ONS Connect; 2008 Jul; 23(7):13. PubMed ID: 18697645
    [No Abstract]   [Full Text] [Related]  

  • 60. Improving communication and support for men with prostate cancer.
    Hiley C
    Nat Clin Pract Oncol; 2006 Jul; 3(7):345. PubMed ID: 16826197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.